Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

April 30, 2006

Study Completion Date

November 30, 2013

Conditions
Breast CancerHot FlashesHot Flushes
Interventions
DIETARY_SUPPLEMENT

soy protein

Given orally

DIETARY_SUPPLEMENT

isoflavones

Given orally

DRUG

Tamoxifen

OTHER

Placebo

Oral

Trial Locations (14)

27534

Wayne Memorial Hospital, Incorporated, Goldsboro

28374

FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center, Pinehurst

28501

Kinston Medical Specialists, Kinston

46350

Center for Cancer Therapy at LaPorte Hospital and Health Services, La Porte

46515

Elkhart General Hospital, Elkhart

46601

CCOP - Northern Indiana CR Consortium, South Bend

Memorial Hospital of South Bend, South Bend

46617

Saint Joseph Regional Medical Center, South Bend

46904

Howard Community Hospital, Kokomo

49085

Lakeland Regional Cancer Care Center - St. Joseph, Saint Joseph

61108

Center for Cancer Care at OSF Saint Anthony Medical Center, Rockford

01605

Commonwealth Hematology-Oncology, PC - Worcester, Worcester

03431

Kingsbury Center for Cancer Care at Cheshire Medical Center, Keene

03756-0002

Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Protein Technologies International

UNKNOWN

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00031720 - Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease | Biotech Hunter | Biotech Hunter